A Safety & Acceptability Study of a Vaginal Ring Microbicide Delivery Method for the Prevention of HIV Infection in Women (IPM011) 
Home > Programmes (40) > STIs & HIV Research (17) > A Safety & Acceptability Study of a Vaginal Ring Microbicide Delivery Method for the Prevention of HIV Infection in Women (IPM011)
 

Project Focus
HIV/AIDS; STIs, HIV Prevention, female controlled methods

Project Location
Yeoville, Johannesburg

Duration of Project
2006 - 2008

Project Partners
International Partnership for Microbicides (IPM)

Project Donors
IPM

Contact
Dr Claire Von Mollendorf

Project Aims /Objectives
While safety and efficacy are critical factors in the development of vaginal microbicides, in order for these products to have an impact on HIV transmission rates, they must also employ delivery methods that are acceptable to potential users.

The favorable response from postmenopausal women to a vaginal ring drug delivery method is promising. However, additional information is needed on the acceptability of the vaginal ring as a drug delivery method among pre-menopausal women, and also among women in geographical regions other than the U.S.

The primary objective of the IPM011 study is to assess the safety and acceptability of a silicone elastomer vaginal ring intended as a microbicide delivery method for the prevention of HIV infection when inserted in place for a 12 week period in healthy sexually active women.

The study will be an open-label cross-over study conducted at a number of sites, with 200 healthy sexually active women.

Project Activities
The project is currently in the start up phase with site readiness activities being undertaken. The protocol has been finalized and submitted for ethical review at the University of the Witwatersrand Human Research Ethics Committee. Budgeting and resourcing are near completion.

Anticipated/Actual Results
Established safety and acceptability of a silicone elastomer vaginal ring as a microbicide delivery method

Additional Outputs
Contribution to protocol development

Future Plans
To enroll and follow up study participants between February 2007 – January 2008 and to conduct focus group discussions to provide additional information to be used in the interpretation of the study’s quantitative behavioural acceptability tool


 Projects in the STI's & HIV Research Cluster:

  A Multi Center Acute HIV-1 Infection Prospective Observational Cohort Study
  DfiD Research Programme Consortium: Consortium for Research and Capacity Building in Reproductive and Sexual Health and HIV/AIDS in developing countries
  A Safety & Acceptability Study of a Vaginal Ring Microbicide Delivery Method for the Prevention of HIV Infection in Women (IPM011)
  Acute HIV infection (AHI) identification
  Contraceptive Research Planning Survey: Comparison of DEPO-PROVERA and IUD Pilot Study
  A phase III randomized, double blind, placebo controlled trial of acyclovir for the reduction of HIV acquisition among high risk HSV2+ HIV- individuals (HPTN039) (known locally as Thembalethu)
  Sub-study to an international multi-centre, randomised, double-blind, placebo-controlled trial to evaluate the efficacy and safety of 0.5% and 2% PRO 2000/5 gels for the prevention of vaginally acquired HPV infection
  A multi-centred randomised trial of therapeutic intervention at primary HIV-1 infection (also known as SPARTAC)
  An international multi-centre, randomised, double-blind, placebo-controlled trial to evaluate the efficacy and safety of 0.5% and 2% PRO 2000/5 gels for the prevention of vaginally acquired HIV infection
  National Research Foundation Thuthuka Programme: Developing & Advancing Excellence in Researchers
  The Safety and feasibility study of the diaphragm used with Acidform gel or KY Jelly
  Evaluation of quadrivalent HPV vaccine in reducing the incidence of anogenital warts and related genital infection in young men
  IPM Microbicide Feasibility Study
  STI/HIV Research Adherence
  STI/HIV Research HSV2 Shedding
  STI/HIV Research Gates PIP
  Focus on Men: A Programme to Improve Male Involvement in Sexual & Reproductive Health (known locally as Mpilonhle-Mpilonde)